What are the possible causes and treatments for vaginal discharge in a reproductive-aged woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vaginal Discharge: Causes and Treatment

In a reproductive-aged woman with vaginal discharge, you must first perform point-of-care testing (vaginal pH, wet mount microscopy, and KOH preparation) to distinguish between the three most common causes: bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis—each requiring different treatment approaches. 1, 2

Diagnostic Algorithm

Step 1: Measure Vaginal pH

  • pH >4.5 suggests bacterial vaginosis or trichomoniasis 1, 2
  • pH ≤4.5 indicates vulvovaginal candidiasis 1, 2

Step 2: Perform Whiff Test

  • Add 10% KOH to vaginal discharge 1, 2
  • Positive fishy odor confirms bacterial vaginosis or trichomoniasis 1, 2

Step 3: Microscopic Examination

  • Saline wet mount: Look for motile trichomonads (trichomoniasis) or clue cells (bacterial vaginosis) 1, 2
  • KOH preparation: Identify yeast or pseudohyphae (candidiasis) 1, 2

Common Causes and Treatments

Bacterial Vaginosis

Clinical presentation:

  • Homogeneous, thin, white-gray discharge with fishy odor 1
  • pH >4.5 with positive whiff test 1
  • Clue cells on microscopy 1

Treatment:

  • Metronidazole 500 mg orally twice daily for 7 days 3
  • Do not treat male partners—this does not prevent recurrence 1

Vulvovaginal Candidiasis

Clinical presentation:

  • Thick, white "cottage cheese-like" discharge 3, 2
  • Intense pruritus and vulvar erythema 4, 1
  • pH <4.5, no odor 1, 3
  • Yeast or pseudohyphae on KOH preparation 1, 2

Treatment for uncomplicated cases:

  • Short-course topical azoles (80-90% cure rate) 4
  • Fluconazole 150 mg orally as single dose (55% cure rate) 2
  • Miconazole 1200 mg vaginal insert as single dose 5

Treatment for complicated/recurrent cases (≥4 episodes per year):

  • Initial longer course (7-14 days) followed by maintenance therapy for 6 months 1
  • Fluconazole 150 mg weekly for 6 months 1
  • Partner treatment may be considered only in women with recurrent infection 4

Trichomoniasis

Clinical presentation:

  • Yellow-green discharge with malodor 1, 2
  • Vulvar irritation and pruritus 2
  • Motile trichomonads on wet mount 2

Treatment:

  • Metronidazole 2 grams orally as single dose (90-95% cure rate) 2
  • Treat sexual partners simultaneously to prevent reinfection 6

Special Population Considerations

Pregnant Women

  • Use only 7-day topical azole therapies for candidiasis—oral fluconazole is contraindicated 4, 1
  • Follow-up evaluation one month after treatment to verify cure 2
  • Suspected pelvic inflammatory disease requires hospitalization and parenteral antibiotics 4

HIV-Infected Women

  • Treatment should not differ from non-HIV-infected women 4, 1

Critical Pitfalls to Avoid

  • Do not treat without proper diagnosis—pH measurement and microscopy are essential before initiating therapy 1
  • Do not treat asymptomatic Candida colonization (present in 10-20% of women) 1
  • Avoid self-medication except for women previously diagnosed with candidiasis experiencing identical symptoms 1
  • Do not use tampons during treatment—they may remove medication from the vagina 5
  • Avoid vaginal douching—it disrupts normal flora and increases infection risk 1
  • Do not assume sexual transmission—bacterial vaginosis and candidiasis are not sexually transmitted diseases 3

When to Refer or Escalate Care

Immediate physician evaluation required if:

  • First episode of vaginal discharge ever 5
  • Fever, chills, lower abdominal, back or shoulder pain, or foul-smelling discharge (suggests pelvic inflammatory disease or sexually transmitted infection) 4, 5
  • Multiple sex partners or new sex partner (rule out sexually transmitted infections) 5
  • Symptoms persist despite treatment within 72 hours 4
  • Recurrent infections (≥4 episodes per year) requiring evaluation for diabetes, immunosuppression, or HIV 4, 5

Follow-Up Recommendations

  • Return only if symptoms persist or recur within 2 months 1, 2
  • Routine test-of-cure is unnecessary if symptoms resolve 2
  • For pelvic inflammatory disease, patients should demonstrate substantial improvement within 3 days or require hospitalization 4

References

Guideline

Treatment for Persistent Vaginal Discharge

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach for Yellow Vaginal Discharge with Pruritus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Considerations for Vaginal Discharge in Post-Hysterectomy, Non-Sexually Active Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Infectious Vaginitis, Cervicitis, and Pelvic Inflammatory Disease.

The Medical clinics of North America, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.